Semaglutide is commonly associated with nausea, vomiting, and diarrhoea, particularly in the early stages of treatment
The SURMOUNT-1 trial (N=2,539), published in the New England Journal of Medicine in 2022 (DOI: 10.1056/NEJMoa2206038), evaluated tirzepatide at 5mg, 10mg, and 15mg weekly doses versus placebo in adults with obesity or overweight
Selected Research References Wilding JPH, et al
To choose a reliable compounding pharmacy for semaglutide and other medicines, look for: 503A compounding pharmacy or 503B outsourcing facility
If you are wondering, "Does insurance cover semaglutide?" or if semaglutide is covered by insurance, our team is here to clarify your coverage and help you start an affordable semaglutide weight loss program